If the company does not make money the bottom point will be almost $0.01 before some other hopeful buys it. This chartism will be seen as just another effort at tea-leaf reading.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game